Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
600 participants
OBSERVATIONAL
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telemedicine Monitoring of Nocturnal Incidents
NCT04328896
Frequency of Hypoglycemia in Patients With Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real Life
NCT03020264
Continuous Glucose Monitoring and Hypoglycemia Unawareness in Type 1 Diabetes
NCT03605979
Impact of Food Carbohydrate and Insulin Dose Computing by on Smart Phone on Glucose Control in Patients With Diabetes
NCT02676609
Glycemic Control Before, During and After the 2016 Paris Marathon
NCT04926298
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Biobanking of urine/blood Collection of key medical informations by investigators
Questionnaires :
* socio-economic status
* Fear of hypoglycemia-2
* Anxiety Depression scale (HAD)
* Health survey (SF36, SF12)
* Satisfaction to treatment (DHP-18)
* Dutch Eating Behavior Questionnaire (DEBQ)
* Pittsburgh quality of sleep (PSQI)
* Blood Glucose diary
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* at least 2 Blood Glucose monitoring daily
* on insulin for more than 5 years
Exclusion Criteria
* below 3 months change in insulin treatment
* other clinical trial
* renal failure (eDFG below 30 ml/min/1.73 m²)
* Pregnancy and/or lactation
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Poitiers University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Tours
Tours, France, France
Angers University Hospital
Angers, , France
Brest University Hospital
Brest, , France
La Roche sur Yon Hospital
La Roche-sur-Yon, , France
La Rochelle Hospital
La Rochelle, , France
CH Bretagne sud
Lorient, , France
Chu de Nantes
Nantes, , France
Poitiers University Hospital
Poitiers, , France
Chu de Rennes
Rennes, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Saulnier PJ, Briet C, Gand E, Chaillous L, Dubois S, Bonnet F, Leguerrier AM, Fradet G, Delcourt Crespin I, Kerlan V, Gouet D, Perlemoine C, Ducluzeau PH, Pichelin M, Wargny M, Gonder-Frederick L, Ragot S, Hadjadj S, Cariou B; VARDIA study group. No association between fear of hypoglycemia and blood glucose variability in type 1 diabetes: The cross-sectional VARDIA study. J Diabetes Complications. 2019 Aug;33(8):554-560. doi: 10.1016/j.jdiacomp.2019.05.003. Epub 2019 May 10.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VARDIA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.